Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
FDA Approves 1st New Schizophrenia Drug in Decades
New schizophrenia drug gets FDA approval, taking novel approach to treating brain disorder
On Thursday, the U.S. Food and Drug Administration approved COBENFY, an oral medication that marks the first new class of drugs for schizophrenia in more than 30 years.
In a Victory for the Free Market, FDA Approves New Schizophrenia Drug
Despite billions of taxpayer dollars spent on mental illness research, Cobenfy was developed by a private biopharmaceutical company.
FDA Approves New Kind of Drug for Schizophrenia
The first new type of medication in decades to help fight against schizophrenia was approved on Thursday by the U.S. Food and Drug Administration. Cobenfy (xanomeline/trospium chloride) could bring patients what they've long hoped for: A means of easing the hallucinations and "voices" that disrupt their lives without the weight gain and sluggishness of current dopamine-focused drugs.
WLRN
2h
A new kind of drug for schizophrenia promises fewer side effects
A medicine that sidesteps the brain's dopamine receptors to reach different targets represents a new approach to ...
Business Wire
3h
U.S. Food and Drug Administration Approves Bristol Myers Squibb’s COBENFY™ (xanomeline and trospium chloride), a First-In-Class Muscarinic Agonist for the Treatment of ...
U.S. FDA Approves Bristol Myers Squibb’s COBENFY, a First-In-Class Muscarinic Agonist for the Treatment of Schizophrenia in Adults ...
10h
on MSN
New schizophrenia drug ‘could change the lives of millions of people’
New schizophrenia drug ‘could change the lives of millions of people’ - The US Food and Drug Administration has approved ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
NC dam failure ‘imminent’
Helene: How to help
High-end brothel plea
'Harry Potter' star dies
Bill to use birth control
Van Gogh paintings attacked
ICE: Convicts roaming free
Troops to leave some bases
Promotes watch collection
Diocese reaches settlement
Stadiums to serve as shelters
Targeted Black residents?
World's oldest cheese found
Meta hit with privacy fine
More executives leave
Fed inflation gauge cools
KY sues Express Scripts
NY ballot appeal rejected
Deposition in AI suit
ISR targets Hezbollah HQ
US charges three Iranians
Killer gets life sentence
Ending password-sharing
Urgent safety alert for 737s
NC board removes 747K
On Secret Service failures
50/50 ball ownership suit
Fake Biden robocalls fine
WI duplicate ballot flap
Pleads not guilty
Producing doc on Diddy
Feedback